Mason Morfit

G. Mason Morfit is CFA and president of ValueAct Capital. He was appointed on Board of Directors of Microsoft in March-2014.^[1][2]

Education

Morfit has B.A. from Princeton University and he is a CFA charter holder.

Career

Morfit joined the ValueAct Capital in January 2001. Prior to that he worked in equity research for Credit Suisse First Boston. He is a director of Valeant Pharmaceuticals International and a former director of Advanced Medical Optics, Inc., C.R. Bard, Inc., Immucor, Inc., MSD Performance, Inc. and Solexa, Inc.^[3]

References

1. Profile, valuewalk.com; accessed September 22, 2014.
2. Profile, softpedia.com; accessed September 22, 2014.
3. Profile, valueact.com; accessed September 22, 2014.